AstraZeneca reveals Wang Lei's latest status, stating that the latest investigation involves two other executives involved in illegal drug imports
楚一帆
发表于 昨天 18:11
117
0
0
On November 6th local time, AstraZeneca UK headquarters provided investors with an update on the latest situation of the company's Chinese executives. At the meeting, AstraZeneca announced that its China regional president, Wang Lei, has been "detained", which is the company's latest response to Wang Lei's current situation.
AstraZeneca China announced on October 30th that its CEO in China, Wang Lei, is "cooperating with the investigation".
On November 5th, AstraZeneca's stock price plummeted by nearly 8%, and its market value evaporated by over £ 15 billion. On November 6th, Aradhana Sarin, the Chief Financial Officer of AstraZeneca, communicated with sell side investors to appease their concerns about the company's current situation.
On November 7th, AstraZeneca China told First Financial reporters that they are currently unaware of the progress of the case.
The first financial reporter learned that on November 6th, AstraZeneca headquarters held an online investor briefing. According to a summary of an investor meeting obtained by reporters, AstraZeneca stated at the meeting that a large-scale investigation into the "insurance fraud case" had been launched as early as three years ago, involving over 100 former AstraZeneca employees, but currently not involving the company's current executives. The AstraZeneca "insurance fraud case" mainly targets the company's star lung cancer drug "Terassa".
The company also revealed at the meeting that two other current executives and two former executives are under investigation, mainly targeting the illegal import and sale of drugs from Hong Kong to mainland China.
The first financial reporter learned from a major institutional investor of AstraZeneca that the information currently held by the institution is basically consistent with what AstraZeneca disclosed to investors on Wednesday. However, based on the limited information currently available, it is still impossible to determine whether these investigations will have a greater impact on AstraZeneca in the future.
According to AstraZeneca's disclosure, the company currently has 12000 employees in China, and sales in China account for approximately 13% of AstraZeneca's global sales. In the past decade, China has also been one of the core markets for AstraZeneca to achieve its global sales targets, and AstraZeneca has made significant investments in China.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Robin Lee, the latest voice!
- Robin Lee's latest voice!
- Reward 30000 yuan for having a third child! Latest response from Miniso
- Baidu recently released Robin Lee Voices!
- Baidu recently released Robin Lee Voices!
- Robin Lee's latest internal voice, "We will survive in 2024 and become butterflies"!
- Robin Lee's latest voice
- 21 Exclusive | Xiaopeng's intelligent business welcomes key talents again: two executives with backgrounds in Gaode and AsiaInfo join Xiaopeng
-
随着“银十”结束,各家造车新势力都交出了一份亮眼的成绩单。 理想领跑10月新势力交付榜,鸿蒙智行重回4万辆,零跑、深蓝、极氪、小鹏等单月交付量均创新高,岚图、阿维塔、智己等实现破万,但哪吒却消失在 ...
- fanadam
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
为期超七周的大罢工终于落下帷幕。 当地时间11月4日,波音美国西海岸工厂工人们就改进后的合同提案投票。 随后,代表着波音超过33000名西雅图地区机械师的IAM工会经表决,以59%的同意票决定接纳波音提 ...
- cristianna
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
“新四化”的时代浪潮下,新能源汽车行业百家争鸣。伴随着自主品牌不断崛起,合资品牌当下的生存状况备受外界关注,如何打好电动化时代的突围战,成为合资品牌的新课题。 作为国内合资车企的代表之一,上汽 ...
- mbgg2797
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
证券时报网讯,热门中概股美股盘前普涨,小鹏汽车、哔哩哔哩涨近5%,蔚来涨超4%,阿里巴巴、拼多多涨超2%。
- p609520
- 3 天前
- 支持
- 反对
- 回复
- 收藏